(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of 4.91% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Inotiv's revenue in 2025 is $480,402,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $17,163,434,868, with the lowest NOTV revenue forecast at $17,163,434,868, and the highest NOTV revenue forecast at $17,163,434,868. On average, 1 Wall Street analysts forecast NOTV's revenue for 2026 to be $18,144,555,920, with the lowest NOTV revenue forecast at $18,144,555,920, and the highest NOTV revenue forecast at $18,144,555,920.
In 2027, NOTV is forecast to generate $19,183,733,505 in revenue, with the lowest revenue forecast at $19,183,733,505 and the highest revenue forecast at $19,183,733,505.